BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05761951-completion@plaintrial.com
DTSTAMP:20261111T014147Z
DTSTART;VALUE=DATE:20290131
SUMMARY:Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 
 (DKK1 Inhibitor\, Leap Therapeutics) and Pembrolizumab in the Treatment of
  Advanced or Recurrent Endometrial Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05761951
URL:https://plaintrial.com/trial/NCT05761951
END:VEVENT
END:VCALENDAR